Joliet Oncology-Hematology Associates Limited — Joliet, Illinois

Joliet Oncology-Hematology Associates Limited is a clinical research site located in Joliet, Illinois, United States 60435.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Joliet Oncology-Hematology Associates Limited has participated in 55 clinical trials with 4 currently active.

Therapeutic areas: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.

Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network, ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Joliet Oncology-Hematology Associates Limited?

Joliet Oncology-Hematology Associates Limited has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Joliet Oncology-Hematology Associates Limited conducted?

Joliet Oncology-Hematology Associates Limited has 55 clinical trials on record, with 4 currently active. Their work covers Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.

Is Joliet Oncology-Hematology Associates Limited accredited by Crixeo Health?

Yes — Joliet Oncology-Hematology Associates Limited holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Joliet Oncology-Hematology Associates Limited?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.